APA (7th ed.) Citation

Glantschnig, L., Enke, J. S., Schuller, B. W., Fenn, E. J., Dierks, A., Patt, M., . . . Lapa, C. (2026). Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry. Journal of Nuclear Medicine, 67(5), 709. https://doi.org/10.2967/jnumed.125.271031

Chicago Style (17th ed.) Citation

Glantschnig, Lisa, et al. "Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry." Journal of Nuclear Medicine 67, no. 5 (2026): 709. https://doi.org/10.2967/jnumed.125.271031.

MLA (9th ed.) Citation

Glantschnig, Lisa, et al. "Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry." Journal of Nuclear Medicine, vol. 67, no. 5, 2026, p. 709, https://doi.org/10.2967/jnumed.125.271031.